These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17237809)

  • 1. Conditional N-rasG12V expression promotes manifestations of neurofibromatosis in a mouse model.
    Saito H; Yoshida T; Yamazaki H; Suzuki N
    Oncogene; 2007 Jul; 26(32):4714-9. PubMed ID: 17237809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis and associated tumour suppressor genes.
    Zwarthoff EC
    Pathol Res Pract; 1996 Jul; 192(7):647-57. PubMed ID: 8880865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line.
    Perrin GQ; Fishbein L; Thomson SA; Thomas SL; Stephens K; Garbern JY; DeVries GH; Yachnis AT; Wallace MR; Muir D
    J Neurosci Res; 2007 May; 85(6):1347-57. PubMed ID: 17335073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
    Buteică E; Stoicescu I; Burada F; Stănoiu B
    Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
    Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
    Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Von Recklinghausen's disease: experimental models and comparative aspects].
    Turusov VS; Kardeza A; Ribal'ta T
    Arkh Patol; 1996; 58(5):3-13. PubMed ID: 9005821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic and molecular pathogenesis of NF1 and NF2.
    Yohay KH
    Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
    Xu J; Ismat FA; Wang T; Yang J; Epstein JA
    Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis.
    Roos KL; Muckway M
    Dermatol Clin; 1995 Jan; 13(1):105-11. PubMed ID: 7712636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocristopathy resembling neurofibromatosis type 1 in an NGF-SV40 transgenic line.
    Mazarakis ND; Yannoutsos N; el-Jabbour JN; Hatton W; Fletcher R; Grosveld F
    Genes Cells; 1996 Jan; 1(1):125-37. PubMed ID: 9078372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling neurofibromatosis type 1 tumors in the mouse for therapeutic intervention.
    Parada LF; Kwon CH; Zhu Y
    Cold Spring Harb Symp Quant Biol; 2005; 70():173-6. PubMed ID: 16869751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of neurofibromatosis 1 and 2.
    Gutmann DH; Giovannini M
    Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice.
    Demestre M; Messerli SM; Celli N; Shahhossini M; Kluwe L; Mautner V; Maruta H
    Phytother Res; 2009 Feb; 23(2):226-30. PubMed ID: 18726924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
    Su W; Xing R; Guha A; Gutmann DH; Sherman LS
    Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
    Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS
    Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
    Dasgupta B; Li W; Perry A; Gutmann DH
    Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour suppressor genes, immunology and local manifestations of neurofibromatosis phenotypes.
    Gerosa PL; Spinelli M; Iannarelli S; Giussani G; Canepari C; Fontana A; Vai C; Bizzozero L
    Panminerva Med; 1996 Sep; 38(3):157-63. PubMed ID: 9009679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
    Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
    Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis.
    McClatchey AI
    Annu Rev Pathol; 2007; 2():191-216. PubMed ID: 18039098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.